FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2082843745> ?p ?o ?g. }

• W2082843745 endingPage "386" @default.
• W2082843745 startingPage "381" @default.
• W2082843745 abstract "Lipid-lowering drugs are one of the most prescribed drugs worldwide. The aim was to compare 10-year all-cause mortality according to initial dyslipidemia status and lipid-lowering drug exposure. The PRIME study was a multicenter population-based prospective cohort study of men recruited in 1991 to 1993, aged 50 to 59 years at baseline, and followed up for 10 years. The 4 groups compared were normolipidemic, untreated dyslipidemic, and dyslipidemic subjects on fibrate or statin therapy. Data were analyzed using multivariate Cox models. The cohort included 7,722 French men (statin group 4.0%, fibrate group 7.9%, untreated dyslipidemic subjects 19.0%, and normolipidemic subjects 69.1%). After 10 years, 4.8% of the sample was lost to follow-up and 416 deaths occurred (cancers 53.1%, cardiovascular diseases 17.1%, and other 29.8%). After adjustment for center, age, educational level, cardiovascular risk factors, lipids, alcohol intake, and history of cardiovascular and severe chronic diseases, hazard ratios (HRs) for all-cause mortality were 0.49 (95% confidence interval [CI] 0.26 to 0.94, p = 0.031) for subjects treated with a statin, 0.65 (95% CI 0.42 to 0.99, p = 0.046) for those on fibrate therapy, and 0.76 (95% CI 0.56 to 1.03, p = 0.080) for normolipidemic men compared with untreated dyslipidemic subjects. In the statin group, HRs for death from cardiovascular disease, cancer, and other causes were 0.55 (p = 0.348), 0.41 (p = 0.067), and 0.68 (p = 0.546) compared with dyslipidemic subjects, respectively. In the fibrate group, HRs were 0.76 (p = 0.499), 0.52 (p = 0.041), and 0.87 (p = 0.746). In conclusion, in this cohort study carried out in a real-life setting, all-cause mortality was significantly lower in dyslipidemic subjects on fibrate or statin therapy than in untreated dyslipidemic patients. No excess risk of noncardiovascular death was observed." @default.
• W2082843745 created "2016-06-24" @default.
• W2082843745 creator A5003724943 @default.
• W2082843745 creator A5005655376 @default.
• W2082843745 creator A5015148283 @default.
• W2082843745 creator A5017946579 @default.
• W2082843745 creator A5032536665 @default.
• W2082843745 creator A5032547625 @default.
• W2082843745 creator A5033321689 @default.
• W2082843745 creator A5062244421 @default.
• W2082843745 creator A5063622310 @default.
• W2082843745 creator A5084502500 @default.
• W2082843745 date "2009-02-01" @default.
• W2082843745 modified "2023-09-30" @default.
• W2082843745 title "Ten-Year All-Cause Mortality in Presumably Healthy Subjects on Lipid-Lowering Drugs (from the Prospective Epidemiological Study of Myocardial Infarction [PRIME] prospective cohort)" @default.
• W2082843745 cites W1973491874 @default.
• W2082843745 cites W2014229873 @default.
• W2082843745 cites W2021863348 @default.
• W2082843745 cites W2022517233 @default.
• W2082843745 cites W2031498851 @default.
• W2082843745 cites W2035095377 @default.
• W2082843745 cites W2043263931 @default.
• W2082843745 cites W2087942162 @default.
• W2082843745 cites W2094317359 @default.
• W2082843745 cites W2125321827 @default.
• W2082843745 cites W2135631433 @default.
• W2082843745 cites W2139168645 @default.
• W2082843745 cites W2139476968 @default.
• W2082843745 cites W2140135184 @default.
• W2082843745 cites W2144362901 @default.
• W2082843745 cites W2167045683 @default.
• W2082843745 cites W2198678228 @default.
• W2082843745 cites W2322095705 @default.
• W2082843745 cites W2400712338 @default.
• W2082843745 cites W4230870013 @default.
• W2082843745 cites W424467158 @default.
• W2082843745 doi "https://doi.org/10.1016/j.amjcard.2008.09.092" @default.
• W2082843745 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19166693" @default.
• W2082843745 hasPublicationYear "2009" @default.
• W2082843745 type Work @default.
• W2082843745 sameAs 2082843745 @default.
• W2082843745 citedByCount "30" @default.
• W2082843745 countsByYear W20828437452012 @default.
• W2082843745 countsByYear W20828437452013 @default.
• W2082843745 countsByYear W20828437452014 @default.
• W2082843745 countsByYear W20828437452015 @default.
• W2082843745 countsByYear W20828437452017 @default.
• W2082843745 countsByYear W20828437452018 @default.
• W2082843745 countsByYear W20828437452019 @default.
• W2082843745 countsByYear W20828437452020 @default.
• W2082843745 countsByYear W20828437452021 @default.
• W2082843745 countsByYear W20828437452022 @default.
• W2082843745 crossrefType "journal-article" @default.
• W2082843745 hasAuthorship W2082843745A5003724943 @default.
• W2082843745 hasAuthorship W2082843745A5005655376 @default.
• W2082843745 hasAuthorship W2082843745A5015148283 @default.
• W2082843745 hasAuthorship W2082843745A5017946579 @default.
• W2082843745 hasAuthorship W2082843745A5032536665 @default.
• W2082843745 hasAuthorship W2082843745A5032547625 @default.
• W2082843745 hasAuthorship W2082843745A5033321689 @default.
• W2082843745 hasAuthorship W2082843745A5062244421 @default.
• W2082843745 hasAuthorship W2082843745A5063622310 @default.
• W2082843745 hasAuthorship W2082843745A5084502500 @default.
• W2082843745 hasConcept C107130276 @default.
• W2082843745 hasConcept C126322002 @default.
• W2082843745 hasConcept C188816634 @default.
• W2082843745 hasConcept C207103383 @default.
• W2082843745 hasConcept C2776839432 @default.
• W2082843745 hasConcept C2776933373 @default.
• W2082843745 hasConcept C2778096610 @default.
• W2082843745 hasConcept C2779134260 @default.
• W2082843745 hasConcept C2908647359 @default.
• W2082843745 hasConcept C44249647 @default.
• W2082843745 hasConcept C500558357 @default.
• W2082843745 hasConcept C50382708 @default.
• W2082843745 hasConcept C71924100 @default.
• W2082843745 hasConcept C72563966 @default.
• W2082843745 hasConcept C99454951 @default.
• W2082843745 hasConceptScore W2082843745C107130276 @default.
• W2082843745 hasConceptScore W2082843745C126322002 @default.
• W2082843745 hasConceptScore W2082843745C188816634 @default.
• W2082843745 hasConceptScore W2082843745C207103383 @default.
• W2082843745 hasConceptScore W2082843745C2776839432 @default.
• W2082843745 hasConceptScore W2082843745C2776933373 @default.
• W2082843745 hasConceptScore W2082843745C2778096610 @default.
• W2082843745 hasConceptScore W2082843745C2779134260 @default.
• W2082843745 hasConceptScore W2082843745C2908647359 @default.
• W2082843745 hasConceptScore W2082843745C44249647 @default.
• W2082843745 hasConceptScore W2082843745C500558357 @default.
• W2082843745 hasConceptScore W2082843745C50382708 @default.
• W2082843745 hasConceptScore W2082843745C71924100 @default.
• W2082843745 hasConceptScore W2082843745C72563966 @default.
• W2082843745 hasConceptScore W2082843745C99454951 @default.
• W2082843745 hasIssue "3" @default.
• W2082843745 hasLocation W20828437451 @default.
• W2082843745 hasLocation W20828437452 @default.
• W2082843745 hasOpenAccess W2082843745 @default.
• W2082843745 hasPrimaryLocation W20828437451 @default.

• next